Medicaid Expansion May Have Improved Access to Cancer Trials
The expansion of Medicaid eligibility was associated with a nearly 3-fold increase in the proportion of Medicaid-covered patients enrolled in cancer treatment trials.
ASCO 2022
High-Deductible Insurance Linked to Delayed Diagnosis of Metastatic Cancer
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
Novel Agent N-803 Safe, Effective for BCG-Unresponsive High-Risk NMIBC
Investigators sought to determine the efficacy and safety of N-803 plus BCG in patients with high-risk NMIBC.
Lack of Access, Not Lack of Interest, Prevents Black Patients From Enrolling in Clinical Trials
More than 80% of Black survey respondents said they were somewhat or very likely to consider enrolling in a clinical trial.
- Loading...
Loading...
Next post in Oncology
Loading... 
Loading...